BioData World Congress

Interview with the President of the European Institute for Innovation through Health Data

The interview was conducted by the DNAdigest team (dnadigest.org) Dipak Kalra is the President of the European Institute for Innovation through Health Data (i~HD). He is also a Professor of Health Informatics at University College London, and  affiliated with University of Gent. He has worked on the clinical, ethical and legal requirements for electronic health records and on the development of international interoperability standards and will present …

Intel

Intel’s Insights from BioData World Congress 2016

One of our sponsors at BioData World Congress– Intel, prepared a post- event article with insights on the most burning topics that were discussed last week. Last week I was pleased to join a host of partners, customers and industry experts at the leafy Genome Campus in Cambridge, UK, for this year’s BioData World Congress. As one of the world’s leading …

Q2 2016 Cloud

Q2 Pharmacovigilance and Drug Safety Conferences – What did you miss?

Q2 Pharmacovigilance and Drug Safety Conferences – What did you miss? Great industry conferences are often the result of a combination of factors: good planning, strong speakers, with real depth in expertise and a passion for their topic, and attendees/delegates with great questions.  When all three line up in one event, all participants gain tremendous value from the presentations and …

Algorics

Press-release: Mednet Solutions announces technology partnership with Algorics

May 19, 2016 Minnetonka, Minn. & Houston, Texas – MedNet Solutions, an innovative SaaS-based eClinical technology company that supports the entire spectrum of clinical research, and Algorics, a provider of cloud-based clinical analytics solutions and software for the global life sciences industry, today unveiled their strategic technology partnership designed to provide superior risk based monitoring (RBM) functionality to MedNet’s customers …

genomeweb whitepaper

Alternative Proposals for Lab Test Regulation

Are There Opportunities for Consensus? A GenomeWeb Report February 2016 Amid multiple proposals on LDT regulation, are there opportunities for consensus? By Turna Ray The lab industry entered 2016 in a staring contest with the US Food and Drug Administration that began two years ago when the agency released its draft guidance on regulating laboratory-developed tests (LDTs). During the course …

TCS whitepaper

Reimagining the Clinical Trials Process through Digital Disruption

Conventional clinical trial processes require significant time and resources to be invested for data cleaning, monitoring, and reporting to the concerned regulatory authorities. This directly influences the cost of the trial, and thus the time to market. Explore how digitization of clinical trial processes can help transform the clinical research industry. The clinical trials industry manages large volumes of patient data …

Sparking innovation with suppliers

WHITEPAPER by: Giles Breault, Principal and co-founder of The Beyond Group. Sammy Rashed, Principal and co-founder of The Beyond Group.  For some time now we have been delving into the question of what procurement teams imagine themselves becoming. The question may seem sophomoric on the surface but there are plenty of indicators that the same old results will no longer earn you a seat …

Thomson reuters report

Thomson Reuters press-release: World Generic Medicines Congress Europe

The World Generic Medicines Congress Europe organized by Health Network Communications brought together industry stakeholders, decision makers, and experts for two days of presentations and discussions focused on market challenges and portfolio strategy. The industry has seen a collapse of traditional commodity generic models, while a new model is emerging from innovation and consolidation, supported by strategic geographic expansion. The …

Designing, Clinical, Program, Biosimilar, Personal, Perspective,

Designing a Clinical Program for a Biosimilar: A personal perspective

At the Biosimilar Drug Development World Europe event 2014, Uwe Gudat, Merck Serono, gave a presentation on “Designing a Clinical Program for a Biosimilar: A personal perspective ” Download and learn: Innovator Clinical Development: A primer Biosimilar Clinical Development: Basics Biosimilar Clinical Development: Details Biosimilar Clinical Development: Conclusions Download Presentation Found this interesting? Join us at next year’s Biosimilar Drug Development World …

clinical partnering, clinical, partnering, clinical trials, clinical outsourcing, outsourcing, clinical outsourcing and partnering world europe

Download: 10 Key Insights on Clinical Partnering

This is the year we can increase the efficiencies of clinical trials through collaboration, innovation and enhancing quality. It is time to take stock on previous partnerships, current projects and future alliances. Where are the opportunities? How can we work differently with our partners? How can we embrace the changing technologies? How can we sustain effective clinical partnerships? These are crucial questions and ones …